|
|
| | Namilumab Basic information |
| Product Name: | Namilumab | | Synonyms: | Namilumab;Research Grade Namilumab(DHC06701);Research Grade Namilumab;Namilumab (anti-GM-CSF) | | CAS: | 1206681-39-1 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Namilumab Structure]() |
| | Namilumab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Namilumab Usage And Synthesis |
| Uses | Namilumab (AMG203) is a human IgG1 monoclonal antibody that binds with high affinity to the GM-CSF ligand, potently neutralizing GM-CSF. Namilumab can be used for the research of rheumatoid arthritis[1]. | | in vivo | Namilumab can be used for the research of rheumatoid arthritis with good tolerance[1]. | | References | [1] Huizinga TWJ, et, al. Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis. Arthritis Res Ther. 2017 Mar 9;19(1):53. DOI:10.1186/s13075-017-1267-3 |
| | Namilumab Preparation Products And Raw materials |
|